For patients with T-ALL/LBL Allogeneic stem cell transplantation post-alloCD7 was shown to be safe, and patients with CD7-positive relapse post-transplant could achieve remission again with alloCD7 re-treatment (186, 189). Here, CD7 is linked to acute lymphoblastic leukemia.